NU UW16B13: A Phase II Study of Neratinib Alone and in Combination with Fulvestrant in Metastatic HER2 Non-amplified but HER2 Mutant Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/1/175/1/20

Funding

  • Washington University St. Louis (NU UW16B13)
  • Puma Biotechnology, Inc. (NU UW16B13)